Volume 134, Issue 4, Pages (April 2008)

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 152, Issue 5, Pages e6 (April 2017)
Volume 133, Issue 3, Pages (September 2007)
Volume 154, Issue 5, Pages (April 2018)
Volume 144, Issue 3, Pages e6 (March 2013)
Volume 114, Issue 5, Pages (May 1998)
Volume 148, Issue 4, Pages (April 2015)
Volume 154, Issue 5, Pages (April 2018)
Volume 9, Issue 3, Pages (March 2009)
Lipids in Liver Disease: Looking Beyond Steatosis
Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol Synthesis  Cecilia Gälman, Bo Angelin, Mats Rudling 
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 146, Issue 4, Pages (April 2014)
Julian R. F. Walters, Ali M. Tasleem, Omer S. Omer, W
Volume 134, Issue 7, Pages (June 2008)
Volume 152, Issue 4, Pages (March 2017)
SMAD About Hepatitis C Virus Cell Entry and Liver Disease
Volume 146, Issue 4, Pages (April 2014)
An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis  Laurie L. Baggio, Qingling Huang,
Volume 126, Issue 1, Pages (January 2004)
Volume 23, Issue 3, Pages (March 2016)
Outcomes Among Living Liver Donors
Volume 150, Issue 2, Pages (February 2016)
Volume 137, Issue 3, Pages e4 (September 2009)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Volume 144, Issue 3, Pages e6 (March 2013)
Volume 134, Issue 7, Pages (June 2008)
This Month in Gastroenterology
Volume 140, Issue 5, Pages (May 2011)
Volume 129, Issue 1, Pages (July 2005)
Volume 152, Issue 5, Pages e6 (April 2017)
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 135, Issue 4, Pages (October 2008)
Volume 20, Issue 5, Pages (November 2014)
Volume 141, Issue 4, Pages e5 (October 2011)
Volume 150, Issue 4, Pages (April 2016)
Volume 133, Issue 6, Pages (December 2007)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 141, Issue 3, Pages e4 (September 2011)
Volume 130, Issue 6, Pages (May 2006)
GATA4 Is Essential for Jejunal Function in Mice
Volume 12, Issue 2, Pages (August 2010)
Volume 13, Issue 8, Pages (November 2015)
Volume 137, Issue 1, Pages (July 2009)
Singling Out Intestinal Epithelial Stem Cells
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 134, Issue 4, Pages (April 2008)
Volume 132, Issue 5, Pages (May 2007)
Toward Individualized Cholesterol-Lowering Treatment in End-Stage Renal Disease  Guenther Silbernagel, MD, Iris Baumgartner, MD, Christoph Wanner, MD,
Volume 7, Issue 2, Pages (February 2008)
Volume 93, Issue 5, Pages (May 1998)
Volume 137, Issue 4, Pages (October 2009)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 7, Issue 1, Pages (April 2014)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Covering the Cover Gastroenterology
Volume 148, Issue 3, Pages (March 2015)
Volume 12, Issue 1, Pages (July 2010)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Lipids in Liver Disease: Looking Beyond Steatosis
The Dawning of a New Editorial Board for Gastroenterology
Volume 155, Issue 6, Pages (December 2018)
Volume 140, Issue 3, Pages (March 2011)
Volume 133, Issue 3, Pages (September 2007)
Frank Lammert, David Q.-H. Wang  Gastroenterology 
Volume 61, Issue 4, Pages (April 2002)
Controversies in Liver Transplantation for Hepatitis C
Volume 1, Issue 5, Pages (May 2005)
Presentation transcript:

Volume 134, Issue 4, Pages 1127-1136 (April 2008) Dramatically Increased Intestinal Absorption of Cholesterol Following Hypophysectomy Is Normalized by Thyroid Hormone  Cecilia Gälman, Ylva Bonde, Manuela Matasconi, Bo Angelin, Mats Rudling  Gastroenterology  Volume 134, Issue 4, Pages 1127-1136 (April 2008) DOI: 10.1053/j.gastro.2008.01.032 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Effects of cholesterol/fat feeding (2% C) of intact and Hx rats (5/group) for 1 week. (A) Serum total cholesterol (solid bars) and triglycerides (open bars). *P < .01, **P < .001 vs intact. (B) Cholesterol lipoprotein profiles by FPLC. Lines show averages of all individuals/group. VLDL/CM, very-low-density lipoproteins/chylomicrons. (C) Hepatic total cholesterol (solid bars) and triglycerides (open bars). *P < .01, **P < .001 vs intact and Hx. (D) LDLR mRNA levels corrected for 18S of pooled liver samples from each group run in triplicate. (E) Cyp7a1 mRNA levels corrected for 18S. Solid bars show means of all individuals in each group Cyp7a1 protein corrected for β-actin (open bars) in liver membranes from each individual. (F) Microsomal Cyp7a1 enzymatic activity (solid bars) and serum levels of C4 (open bars). All results show means ± SEM. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Cholesterol absorption in intact (n = 8) and Hx rats (n = 10). (A) Fecal dual-isotope measurement of intestinal cholesterol absorption. (B) Serum plant sterols. All results show mean ± SEM. *P < .05, **P < .01, ***P < .0001, t test vs intact. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Effects of cholesterol absorption blockade on Hx rats during cholesterol/fat feeding. Hx rats (6/group) received standard chow or chow enriched with 0.4% or 2% cholesterol/10% corn oil ± ezetimibe (EZE) (3 mg/kg/day) for 1 week. (A) Cholesterol lipoprotein profiles by FPLC. Lines show averages from all individuals/group. (B) Enlargement of the cholesterol lipoprotein profiles for Hx rats on standard chow ± ezetimibe to clarify the reduction (P < .05) of lipoprotein cholesterol by EZE (solid lines, mean; broken lines, ±SEM). Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 Effects of cholesterol absorption inhibition by ezetimibe on Hx rats during cholesterol/fat feeding. (A) Serum total cholesterol (shaded bars) and triglycerides (solid bars). (B) Serum plant sterols. (C) Serum C4 levels. (D) HMG-CoAR microsomal activity. (E) LDLR mRNA (shaded bars) and SREBP2 mRNA (solid bars) determined on all individuals corrected for 18S. All results are expressed as mean ± SEM. ***P < .001 vs Hx, ###P < .001 vs 0.4% chol, †††P < .001 vs 2% chol. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Effects of hormonal substitution of Hx rats on serum plant sterols. Hx rats (n = 52) were substituted with GH (1.5 mg/kg/day), T4 (42 μg/kg/day), and cortisone (C) (400 μg/kg/day) for 1 week. Intact rats (I) (n = 5) and the Hx control group received subcutaneous injections of NaCl. †P < .05 vs intact; *P < .01, **P < .001 vs Hx; ns, not significant. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 6 Effect of hypophysectomy and substitution of Hx rats with T4 (42 μg/kg/day) for 1 week. Intact (n = 10), Hx (n = 10), and Hx rats treated with T4 (Hx+T4) (n = 9). (A) Cholesterol absorption was determined by the fecal dual-isotope method. (B) Intestinal ABCG5 (solid bars), ABCG8 (shaded bars), and NPC1L1 mRNA (open bars). (C). Hepatic ABCG5 (open bars) and ABCG8 (solid bars) mRNA. (D) Assay of fecal neutral sterols cholesterol (solid bars), coprostanol (medium shaded), cholestanol (dark shaded), campesterol (open bars), and coprostane-3-one (light bars). Comparisons shown are intact vs Hx and Hx vs Hx+T4. *P < .01; **P < .001; ns, not significant. All results shown are means ± SEM. mRNA was determined in all individual animals. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 7 Hepatic ABCG5 mRNA (solid bars) and ABCG8 (open bars) in (A) experiment described in legend of Figure 6. ###P < .001 vs intact, *P < .05, ***P < .001 vs Hx. (B) Experiment on Hx animals only as described in legends of Figures 4 and 5. *P < .05, **P < .01, ***P < .001 vs Hx. (C) Experiment described in legends of Figures 1 and 2. ###P < .001 vs intact, ***P < .001 vs Hx. All results shown are means from all individuals/group ± SEM. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 8 Effect of T4 treatment (42 μg/kg/day for 8 days) of intact and Hx rats (intact [n = 9], intact+T4 [n = 8], Hx [n = 9], and Hx+T4 [n = 5]) on (A) biliary secretion of cholesterol and (B) expression of hepatic ABCG5 mRNA (solid bars) and ABCG8 (open bars) corrected for 18S. Results shown are means of all individuals/group ± SEM. #P < .05, ##P < .01, ###P < .001 vs intact; ***P < .001 vs Hx. Gastroenterology 2008 134, 1127-1136DOI: (10.1053/j.gastro.2008.01.032) Copyright © 2008 AGA Institute Terms and Conditions